Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Classificação em ações #425
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health... Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Preço da ação
$116.80
Valor de mercado
$51.47B
Variação (1 dia)
0.75%
Variação (1 ano)
-27.59%
País
US
Negociar Zoetis Inc. (ZTS)

Categoria

Rácio P/E de Zoetis Inc. (ZTS)
Rácio P/E em March 2026 TTM: 18.95
De acordo com os últimos relatórios financeiros e o preço das ações da Zoetis Inc., o rácio P/E atual (TTM) é 18.95. No final de 2023, a empresa tinha um P/E de 38.83.
Histórico do rácio P/E da Zoetis Inc. de 2009 a 2026
Rácio P/E no final de cada ano
Ano Índice P/E Alterar
2026 (TTM) 18.95 -36.33%
2024 29.77 -23.34%
2023 38.83 19.46%
2022 32.51 -42.80%
2021 56.83 18.28%
2020 48.04 13.88%
2019 42.19 45.79%
2018 28.94 -29.16%
2017 40.85 26.39%
2016 32.32 -54.24%
2015 70.64 91.00%
2014 36.98 14.03%
2013 32.43 -8.80%
2012 35.56 -41.24%
2011 60.52 -55.10%
2010 134.79 -190.91%
2009 -148.27 0.00%
Rácio P/E para empresas semelhantes ou concorrentes
Empresa Rácio P/E Diferença do rácio P/E País
17.97 -5.19%
DE
28.23 48.92%
FR
79.35 318.66%
JP
-0.65 -103.41%
IL
22.30 17.66%
GB
Como interpretar um P/E Ratio?

O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.

Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.

Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.